Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 171

1.

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A Consensus Paper by the European Myeloma Network and the Italian Society of Arterial Hypertension.

Bringhen S, Milan A, D'Agostino M, Ferri C, Wäsch R, Gay F, Larocca A, Offidani M, Zweegman S, Terpos E, Goldschmidt H, Cavo M, Ludwig H, Driessen C, Auner H, Caers J, Gramatzki M, Dimopoulos MA, Boccadoro M, Einsele H, Sonneveld P, Engelhardt M.

J Intern Med. 2019 Feb 6. doi: 10.1111/joim.12882. [Epub ahead of print]

PMID:
30725503
2.

Nutrients and Nutraceuticals for the Management of High Normal Blood Pressure: An Evidence-Based Consensus Document.

Cicero AFG, Grassi D, Tocci G, Galletti F, Borghi C, Ferri C.

High Blood Press Cardiovasc Prev. 2019 Feb;26(1):9-25. doi: 10.1007/s40292-018-0296-6. Epub 2019 Jan 22.

PMID:
30671873
3.

Poor Oral Health and Blood Pressure Control Among US Hypertensive Adults: Results From the National Health and Nutrition Examination Survey 2009 to 2014

Pietropaoli D, Del Pinto R, Ferri C, Wright JT Jr, Giannoni M, Ortu E, Monaco A.

Hypertension. 2018 Oct 22;72(6):1365-1373. doi: 10.1161/HYPERTENSIONAHA.118.11528. [Epub ahead of print]

PMID:
30525343
4.

Poor Oral Health and Blood Pressure Control Among US Hypertensive Adults.

Pietropaoli D, Del Pinto R, Ferri C, Wright JT Jr, Giannoni M, Ortu E, Monaco A.

Hypertension. 2018 Dec;72(6):1365-1373. doi: 10.1161/HYPERTENSIONAHA.118.11528.

PMID:
30540406
5.

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?

Duro G, Zizzo C, Cammarata G, Burlina A, Burlina A, Polo G, Scalia S, Oliveri R, Sciarrino S, Francofonte D, Alessandro R, Pisani A, Palladino G, Napoletano R, Tenuta M, Masarone D, Limongelli G, Riccio E, Frustaci A, Chimenti C, Ferri C, Pieruzzi F, Pieroni M, Spada M, Castana C, Caserta M, Monte I, Rodolico MS, Feriozzi S, Battaglia Y, Amico L, Losi MA, Autore C, Lombardi M, Zoccali C, Testa A, Postorino M, Mignani R, Zachara E, Giordano A, Colomba P.

Int J Mol Sci. 2018 Nov 23;19(12). pii: E3726. doi: 10.3390/ijms19123726.

6.

Inflammation-Accelerated Senescence and the Cardiovascular System: Mechanisms and Perspectives.

Del Pinto R, Ferri C.

Int J Mol Sci. 2018 Nov 22;19(12). pii: E3701. doi: 10.3390/ijms19123701. Review.

7.

Hypertension Management at Older Age: An Update.

Del Pinto R, Ferri C.

High Blood Press Cardiovasc Prev. 2019 Feb;26(1):27-36. doi: 10.1007/s40292-018-0290-z. Epub 2018 Nov 22. Review.

PMID:
30467638
8.

Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study.

Casula M, Olmastroni E, Pirillo A, Catapano AL; MEMBERS OF THE LIPIGEN STEERING COMMETTEE; PRINCIPAL INVESTIGATORS: Coordinator center; Participant Centers; Participant Laboratories; COLLABORATORS; STUDY CENTRAL LABORATORY AND ANALYSIS GROUP.

Atherosclerosis. 2018 Oct;277:413-418. doi: 10.1016/j.atherosclerosis.2018.08.013.

PMID:
30270079
9.

Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy.

Volpe M, Battistoni A, Gallo G, Rubattu S, Tocci G; Writing Committee; Scientific Societies.

High Blood Press Cardiovasc Prev. 2018 Sep;25(3):327-341. doi: 10.1007/s40292-018-0278-8. Epub 2018 Sep 20. Review.

PMID:
30232768
10.

Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA).

Bringhen S, Milan A, Ferri C, Wäsch R, Gay F, Larocca A, Salvini M, Terpos E, Goldschmidt H, Cavo M, Petrucci MT, Ludwig H, Auner HW, Caers J, Gramatzki M, Boccadoro M, Einsele H, Sonneveld P, Engelhardt M; European Hematology Association, the European Myeloma Network and the Italian Society of Arterial Hypertension.

Haematologica. 2018 Sep;103(9):1422-1432. doi: 10.3324/haematol.2018.191288. Epub 2018 Jul 26. Review.

11.
12.

Diastolic blood pressure and risk profile in renal and cardiovascular diseases. Results from the SPRINT trial.

Del Pinto R, Pietropaoli D, Ferri C.

J Am Soc Hypertens. 2018 Jul;12(7):513-523.e3. doi: 10.1016/j.jash.2018.04.004. Epub 2018 May 5.

PMID:
29803637
13.

Considerations on stroke in atrial fibrillation despite anticoagulation.

Di Giosia P, Giorgini P, Ferri C.

J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e54-e57. doi: 10.2459/JCM.0000000000000602. No abstract available.

PMID:
29538145
14.

[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018].

Volpe M, Tocci G, Accettura D, Battistoni A, Bellone S, Bellotti P, Bertolotti M, Borghi C, Casasco M, Consoli A, Coppini R, Corsini A, Costanzo G, Desideri G, Ferri C, Galanti G, Giada F, Icardi G, Lombardi N, Modena MG, Modesti PA, Monti G, Mugelli A, Orsi A, Parati G, Pedretti RF, Perseghin G, Pirro M, Ricotti R, Rizzoni D, Rotella C, Rubattu S, Salvetti G, Sarto P, Tassinari F, Trimarco B, de Kreutzenberg SV, Volpe R.

G Ital Cardiol (Rome). 2018 Feb;19(2 Suppl 1):1S-95S. doi: 10.1714/2874.28988. Italian.

PMID:
29531376
15.

Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term.

Rossi GP, Maiolino G, Flego A, Belfiore A, Bernini G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Muiesan ML, Mannelli M, Negro A, Palumbo G, Parenti G, Rossi E, Mantero F; PAPY Study Investigators.

Hypertension. 2018 Apr;71(4):585-591. doi: 10.1161/HYPERTENSIONAHA.117.10596. Epub 2018 Feb 26.

PMID:
29483224
16.

Gender Differences in Epidemiology, Pathophysiology, and Treatment of Hypertension.

Di Giosia P, Giorgini P, Stamerra CA, Petrarca M, Ferri C, Sahebkar A.

Curr Atheroscler Rep. 2018 Feb 14;20(3):13. doi: 10.1007/s11883-018-0716-z. Review.

PMID:
29445908
17.

Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study.

Desideri G, Virdis A, Casiglia E, Borghi C; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension.

High Blood Press Cardiovasc Prev. 2018 Jun;25(2):197-202. doi: 10.1007/s40292-018-0250-7. Epub 2018 Feb 9.

PMID:
29427170
18.

Proprotein Convertase Subtilisin-Kexin Type 9 (PCSK9) Inhibitors and Cardiovascular Risk: Does a Further Analysis of the Fourier Trial Suggest Changes in the Target of Lipid Lowering Therapy?

Cervelli N, Tocci G, Ferri C.

High Blood Press Cardiovasc Prev. 2018 Mar;25(1):5-7. doi: 10.1007/s40292-017-0244-x. Epub 2018 Jan 5. No abstract available.

PMID:
29305812
19.

Diet and Brain Health: Which Role for Polyphenols?

Castelli V, Grassi D, Bocale R, d'Angelo M, Antonosante A, Cimini A, Ferri C, Desideri G.

Curr Pharm Des. 2018;24(2):227-238. doi: 10.2174/1381612824666171213100449.

PMID:
29237377
20.

Neurocognitive performance after PCSK9 inhibitor therapy: Current state of the evidence.

Stamerra CA, Di Giosia P, Giorgini P, De Feo M, Grassi D, Ferri C, Sahebkar A.

J Neurosci Res. 2018 May;96(5):762-764. doi: 10.1002/jnr.24199. Epub 2017 Nov 20. No abstract available.

PMID:
29152786

Supplemental Content

Loading ...
Support Center